ArticleAnnals of translational medicine2021

Cost-effectiveness of Anbainuo plus methotrexate compared to conventional disease-modifying antirheumatic drugs for rheumatoid arthritis patients in China.

Feng Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.